MARC details
| 000 -LEADER |
|---|
| fixed length control field |
07161nam a2200397 i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
TH-BaNU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231012142857.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
231011s2023 xxuad of 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323791359 |
| 040 ## - CATALOGING SOURCE |
|---|
| Description conventions |
rda |
| Original cataloging agency |
TH-BaNU |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WJ378 |
| Item number |
์์N361 2023 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Handbook of dialysis therapy / |
| Statement of responsibility, etc. |
edited by Allen R. Nissenson, Richard N. Fine, Rajnish Mehrotra, Joshua Zaritsky. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
6th edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Philadelphia, PA |
| Name of producer, publisher, distributor, manufacturer |
Elsevier |
| Date of production, publication, distribution, manufacture, or copyright notice |
2023 |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2023. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xxxi, 807 pages) : |
| Other physical details |
color illustrations, charts. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent. |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Source |
rdamedia. |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Source |
rdacarrier. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical reference and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Demographics of the End-Stage Renal Disease Patient -- 2. Uremic Toxicity -- 3. Initiation of Dialysis Therapy -- 4. Urea Kinetic Modeling for Guiding Hemodialysis Therapy in Adults -- 5. The Dialysis Prescription -- 6. Selecting a Dialyzer: Technical and Clinical Considerations -- 7. Water Treatment Equipment for In-Center Hemodialysis -- 8. Dialysate Composition -- 9. Safety Monitors in Hemodialysis -- 10. Methods of Hemodialysis Anticoagulation -- 11. Common Clinical Problems in Hemodialysis -- 12. Hemofiltration and Hemodiafiltration -- 13. Wearable and Implantable Renal Replacement Therapy -- 14. Home Preparation and Installation for Home Hemodialysis -- 15. Vascular Access -- 16. Cannulation of Arteriovenous Vascular Access: Science and Art -- 17. Central Venous Access for Hemodialysis -- 18. Noninfectious Complications From Vascular Access -- 19. Infectious Complications From Vascular Access -- 20. Determination of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Prescriptions -- 21. Peritoneal Dialysis Cyclers and Other Mechanical Devices -- 22. Peritoneal Dialysis Solutions -- 23. Solute Management With Peritoneal Dialysis -- 24. Volume Management With Peritoneal Dialysis -- 25. Peritoneal Access Devices, Placement Techniques, and Maintenance -- 26. Peritoneal Catheter Exit Site and Tunnel Infections -- 27. Peritonitis in Peritoneal Dialysis -- 28. Abdominal Hernias With Peritoneal Dialysis -- 29. Dialysate Leaks with Peritoneal Dialysis -- 30. Hydrothorax and Peritoneal Dialysis -- 31. Abdominal Catastrophes, Peritoneal Eosinophilia, and Other Unusual Events in Peritoneal Dialysis -- 32. Metabolic Complications of Peritoneal Dialysis -- 33. Acid–Base Homeostasis in Dialysis -- 34. Nutritional Management of Hemodialysis Patients -- 35. Intradialytic Parenteral Nutrition and Intraperitoneal Nutrition -- 36. Nutritional Management in Peritoneal Dialysis -- 37. Anemia and Its Treatment in Patients With End-Stage Kidney Disease -- 38. Resistance to Erythropoiesis Stimulating Agent (ESA) Treatment -- 39. Chronic Kidney Disease–Mineral and Bone Disorder -- 40. Phosphate Management in Patients with End-Stage Kidney Disease -- 41. Use of Vitamin D Sterols and Calcimimetics in Patients With End-Stage Renal Disease -- 42. Parathyroidectomy -- 43. Acquired Cystic Kidney Disease -- 44. The Challenges of Blood Pressure Control in Hemodialysis Patients -- 45. Arrhythmias in Hemodialysis Patients -- 46. Management of Ischemic Heart Disease, Heart Failure, and Pericarditis in Patients Undergoing Long-Term Dialysis -- 47. Avoidance and Treatment of Cardiovascular Disease in Dialysis -- 48. Management of Dyslipidemia in Long-Term Dialysis Patients -- 49. End-Stage Kidney Failure in the Diabetic Patient -- 50. Care of Elderly Dialysis and End-Stage Kidney Disease Patients -- 51. Liver Disease and Gastrointestinal Disorders in Dialysis Patients -- 52. Abnormalities of Thyroid Function in Chronic Dialysis Patients -- 53. Care of the Human Immunodeficiency Virus–Infected End-Stage Kidney Disease Patient -- 54. COVID-19 and Dialysis Patients -- 55. Psychosocial Issues in Patients Treated With Dialysis -- 56. Evaluation and Treatment of Sexual Dysfunction -- 57. Pregnancy in Dialysis Patients -- 58. Principles of Drug Usage in Dialysis Patients -- 59. Medication Management -- 60. Physical Activity, Function, and Exercise-Based Rehabilitation for People on Dialysis -- 61. Physical, Psychosocial, and Vocational Rehabilitation of Patients Undergoing Long-Term Dialysis -- 62. Preventive Care in End-Stage Renal Disease -- 63. Ethical Considerations in the Care of Dialysis Patients: The New Paradigm -- 64. Improving Outcomes for End-Stage Renal Disease Patients: Shifting the Quality Paradigm -- 65. Quality, Safety, Accountability, and Medical Director Responsibilities -- 66. Application of Telemedicine to Kidney Failure Patients -- 67. Continuous Renal Replacement Therapies for Acute Kidney Injury -- 68. Anticoagulation for Continuous Renal Replacement Therapy -- 69. Treatment of Poisoning with Extracorporeal Methods -- 70. Vascular Access and Peritoneal Dialysis Catheter Placement in Children -- 71. Infant Hemodialysis -- 72. Urea Kinetic Modeling for Hemodialysis Prescription in Children -- 73. Alternate Hemodialysis Prescriptions in Children -- 74. Anticoagulation in Children Undergoing Hemodialysis, Continuous Renal Replacement Therapy, or Apheresis Therapy -- 75. Prescribing Peritoneal Dialysis in Children -- 76. Nutritional Management of Children Undergoing Peritoneal Dialysis -- 77. Peritoneal Dialysis in Neonates and Infants -- 78. Dialysis for Inborn Errors of Metabolism -- 79. Neurocognitive Function in Pediatric Dialysis -- 80. Growth in Children With End-Stage Kidney Disease -- 81. Adequacy of Peritoneal Dialysis/Assessing Peritoneal Function in Pediatric Patients -- 82. Continuous Renal Replacement Therapy in Pediatric Patients -- 83. Prevention and Treatment of Bone Disease in Pediatric Dialysis Patients -- 84. Management of Anemia in Children Undergoing Dialysis -- 85. Prevention and Treatment of Cardiovascular Complications in Children Undergoing Dialysis -- 86. Infectious Complications in Children Undergoing Dialysis -- 87. Caring for the Teenager in an Adult Unit. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Edited and written by top experts and pioneers in dialysis, Handbook of Dialysis Therapy, 6th Edition, provides the entire dialysis team with a comprehensive overview of this growing field. It covers traditional and advanced procedures, what pitfalls to expect and how to overcome them, and how best to treat various patient populations—all with a practical approach that can be directly applied to patient care. This must-have resource has been updated with the latest cutting-edge technology, dialysis techniques, and complications related to various diseases for both pediatric and adult patients. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Hemodialysis. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Renal Dialysis. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
COVID-19. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nissenson, Allen R., |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Fine, Richard N., |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Mehrotra, Rajnish, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Zaritsky, Joshua, |
| Relator term |
editor. |
| 850 ## - HOLDING INSTITUTION |
|---|
| Holding institution |
Kuakarun Nursing Library |
| 856 4# - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://www.clinicalkey.com/#!/browse/book/3-s2.0-C20190055136">https://www.clinicalkey.com/#!/browse/book/3-s2.0-C20190055136</a> |
| Link text |
ClinicalKey |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
|---|
| a |
.b23381802 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
National Library of Medicine Classification |
| Koha item type |
General Book |
| 990 ## - EQUIVALENCES OR CROSS-REFERENCES [LOCAL, CANADA] |
|---|
| Link information for 9XX fields |
fme_clinicalkey |
| 998 ## - STAFF NAME (NMU) |
|---|
| Cataloger |
nuch |
